Patents and investors: how a pending application changes your fundraise

Introduction

Fundraising is pattern-matching. In a one-hour meeting, an investor has to form a view on a team, a market, a product, a moat and a valuation. They do this by reaching for shortcuts: heuristics that correlate with good outcomes in their past portfolio. Patent status is one of those shortcuts. Understanding why it works, and how to use it, is one of the cheapest fundraising advantages available to a technical founder.

‍

What do investors actually look for in a patent?

Most investors are not patent attorneys. They will not read your claims, analyse your specification, or benchmark your prior art. What they will do is ask a single question, often obliquely, sometimes directly: "How protectable is this?"

What they want inside that question is a structured answer that signals three things: you understand your own moat, you have taken action to secure it, and the action is credible. "We plan to file next year" fails all three. "We have a pending application filed with the EPO through brantsandpatents" passes all three, in one sentence.

‍

What does the data say about patents and valuations?

A growing body of research tracks how IP status affects early-stage valuations. The consistent finding across European deep-tech samples: startups with filed IP raise at measurably higher valuations than otherwise-identical startups without. The effect size varies by sector. It is largest in hardware, medtech, clean-tech and deep software, and smallest in pure consumer plays. But the direction is unambiguous.

The intuition is simple. Investors price defensibility into their models. A company with no IP gets priced at "speed-dependent" multiples: they only win if they stay ahead operationally, forever. A company with IP gets priced at "moat-protected" multiples: their lead is structurally defended, not just operationally earned. The multiple difference reflects a real difference in the risk profile of the asset.

‍

Why "patent pending" is often more useful than "patent granted"

A common founder misconception: a patent is not valuable until it is granted. This is wrong in two ways.

First, the priority date is what determines your rights against later filers, not the grant date. The day you file, you have blocked everyone else from patenting the same invention for twelve months, worldwide. Grant is confirmation of what you already locked in.

Second, for fundraising purposes, "pending" is often more valuable than "granted". Granted patents are known quantities; pending applications still have narrative upside. An investor hears "pending" and reads optionality. Claims can still be adjusted, the international strategy is still open, and the application can be used as a negotiating position in partnerships. A granted patent is settled. A pending application is alive.

‍

What to put in the deck and the data room

For the deck, one slide is enough. Include at minimum:

• The filing authority (EPO).
• The filing date or filing reference.
• The subject matter of the claims in one plain-English sentence.
• The drafting attorney firm.
• Next steps such as PCT filing at month 12 or national-stage entry.

For the data room: the filing receipt, the application number, the attorney's contact, and a summary of the claims. Investors' technical diligence partners will look at the claims to see if they describe something narrow and defensible (good) or something broad and unlikely to grant (bad). A well-drafted early application strikes a specific balance: broad enough to matter, narrow enough to survive examination. This is where attorney validation is not a luxury.

‍

The cost-benefit calculation, honestly

Consider a seed-stage company raising €1.5M at a €6M pre-money valuation. Assume conservatively that a pending patent lifts the pre-money by 10%. That is below the effect sizes reported in most European studies. It represents €600,000 of value created at the cap table. Against that, a European filing through ptntpwr costs €1,999: 0.33% of the upside.

Under almost any reasonable assumption, the return on filing before fundraising outweighs the cost by one to two orders of magnitude. The founders who defer filing to save cash are, in fundraising terms, picking up pennies in front of a steamroller.

‍

When does this not apply?

If the core value of your company is not technical, patents may not move investor perception. The heuristic is tuned for technical defensibility. For a non-technical play, invest in trademarks instead, and focus the defensibility conversation on network effects or unit economics.

For everyone else: hardware, software with novel architecture, medtech, chemistry, robotics, materials. Filing before the round is not a luxury. It is the cheapest valuation lever available.

‍

Conclusion

Fundraising rewards founders who remove doubts before the investor has to raise them. Patent status is a doubt that gets raised in almost every technical deal. Filing early answers it, in advance, with one sentence.

The cost is a few hours on the wizard, a fixed fee, and a few days waiting on your attorney's draft. The return is a better term sheet.

File your patent before your next round.

‍

Frequently asked questions

‍

How does a patent application help during fundraising?

A pending patent application answers the investor defensibility question with a concrete, verifiable action rather than a plan. It signals that the invention has been assessed as novel by a qualified attorney, that the priority date is locked, and that no competitor can patent the same idea from this point forward. Research on European startups shows that filed IP consistently correlates with higher valuations at seed and Series A.

‍

Do investors check whether a startup has a patent?

Yes, typically during due diligence. Investors rarely read the claims themselves, but they verify that an application exists, check the filing date, review the subject matter, and assess whether the claimed invention covers the actual source of competitive advantage. A well-drafted application on the core technical mechanism is more valuable in this context than multiple applications on peripheral features.

‍

Is "patent pending" useful before the patent is granted?

Yes, significantly. Patent pending status is legally meaningful from the day of filing. It gives you a documented priority date, allows you to mark products and materials accordingly, deters potential copiers who face retrospective enforcement once the patent grants, and signals credibility to investors and commercial partners. For most startups, pending status provides the majority of a patent's commercial value, years before grant arrives.

‍

What should a startup include in its investor data room regarding patents?

At minimum: the filing receipt with the application number and filing date, the subject matter of the claims summarised in plain English, the name of the drafting attorney or firm, and a note on next steps such as PCT filing or national-stage entry. Investors' technical advisers will review the claims for scope and defensibility. A clearly drafted application on the core invention is more persuasive than a broad or vague one.